For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
Metabolic Research Peptide
Cagrilintide
A long-acting acylated amylin analog of 37 amino acids, studied in clinical research for its action at amylin and calcitonin receptors involved in appetite regulation.
Quantity
$69.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
Cagrilintide
1 × 10mg · $69.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
10mg
99.87%latest
| Tested | Measured | Purity |
|---|---|---|
| May 2026 | 11.23mg | 99.87% |
| Feb 2026 | 11.97mg | 99.94% |
| Nov 2025 | 11.69mg | 99.53% |
Frequently researched together
Commonly studied alongside Cagrilintide.
Compound information
Technical specifications
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- New England Journal of Medicine
Coadministered Cagrilintide and GLP-1 (S) in Adults with Overweight or Obesity
2025·DOI: 10.1056/NEJMoa2502081Garvey WT, Blüher M, Osorto Contreras CK et al.
View source - The Lancet
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2021·PMID: 34798060Lau DCW et al.
View source - The Lancet
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with GLP-1 (S) 2.4 mg for weight management: a randomised, controlled, phase 1b trial
2021·PMID: 33894838Enebo LB et al.
View source - Nature Communications
Structural and dynamic features of cagrilintide binding to calcitonin-family receptors
2025View source - Journal of Medicinal Chemistry
Development of Cagrilintide, a Long-Acting Amylin Analogue
2021View source - Cardiology in Review
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
2024·DOI: 10.1097/CRD.0000000000000513·PMID: 36883831D'Ascanio AM, Mullally JA, Frishman WH
View source - PMC
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3
2025View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.